DONOR LEUKOCYTE INFUSIONS AS TREATMENT OF EPSTEIN-BARR-VIRUS LYMPHOPROLIFERATIVE DISORDERS (EBV-LPD) IN RECIPIENTS OF UNRELATED AND RELATED ALLOGENEIC TRANSPLANTS

被引：0
|
作者：
PAPADOPOULOS, EB [1 ]
LADANYI, M [1 ]
机构：
[1] MEM SLOAN KETTERING CANC CTR,NEW YORK,NY 10021
来源：
BLOOD | 1993年 / 82卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A214 / A214
页数：1
相关论文
共 50 条
  • [41] EPSTEIN-BARR-VIRUS RELATED POST-BONE-MARROW-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE - ASSOCIATION WITH CYTOMEGALO-VIRUS INFECTION AND DOWN SYNDROME DONOR MARROW
    PATTON, DF
    WILKOWSKI, C
    HANSON, CA
    KERSEY, JH
    BOSTROM, B
    MCCLAIN, KL
    AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1989, 11 (04): : 429 - 432
  • [42] Epstein-Barr Virus-Related Post-Transplantation Lymphoproliferative Disorders After Allogeneic Hematopoietic Stem Cell Transplantation
    Liu, Li
    Zhang, Xuyan
    Feng, Sizhou
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (07) : 1341 - 1349
  • [43] EPSTEIN-BARR VIRUS RELATED POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS IN PAEDIATRIC ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANT SETTING
    Cheng, Wai Tsoi Frankie
    Lee, Vincent
    To, Ka Fai
    Chan, Paul Kay Sheung
    Leung, Wing Kwan
    Shing, Ming Kong
    Li, Chi Kong
    PEDIATRIC BLOOD & CANCER, 2011, 57 (05) : 818 - 819
  • [44] EPSTEIN-BARR-VIRUS LATENT AND REPLICATIVE GENE-EXPRESSION IN POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS AND AIDS-RELATED NON-HODGKINS-LYMPHOMAS
    REA, D
    DELECLUSE, HJ
    HAMILTONDUTOIT, SJ
    MARELLE, L
    JOAB, I
    EDELMAN, L
    FINET, JF
    RAPHAEL, M
    ANNALS OF ONCOLOGY, 1994, 5 : S113 - S116
  • [45] Refractory Epstein-Barr Virus (EBV)-Related Post-transplant Lymphoproliferative Disease: Cure by Combined Brentuximab Vedotin and Allogeneic EBV-Specific T-Lymphocytes
    Mika, Thomas
    Strate, Katharina
    Ladigan, Swetlana
    Aigner, Clemens
    Schlegel, Uwe
    Tischoff, Iris
    Tischer-Zimmermann, Sabine
    Eiz-Vesper, Britta
    Maecker-Kolhoff, Britta
    Schroers, Roland
    FRONTIERS IN MEDICINE, 2019, 6
  • [46] Epstein–Barr virus-related lymphoproliferative disease complicating childhood acute lymphoblastic leukemia: no recurrence after unrelated donor bone marrow transplantation
    C Pondarré
    K Kebaili
    F Dijoud
    T Basset
    N Philippe
    Y Bertrand
    Bone Marrow Transplantation, 2001, 27 : 93 - 95
  • [47] Infusion of autologous Epstein-Barr virus (EBV) -: specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication
    Comoli, P
    Labirio, M
    Basso, S
    Baldanti, F
    Grossi, P
    Furione, M
    Viganò, M
    Fiocchi, R
    Rossi, G
    Ginevri, F
    Gridelli, B
    Moretta, A
    Montagna, D
    Locatelli, F
    Gerna, G
    Comoli, P
    BLOOD, 2002, 99 (07) : 2592 - 2598
  • [48] INCREASED LEVELS OF CIRCULATING EPSTEIN-BARR-VIRUS (EBV)-INFECTED LYMPHOCYTES AND DECREASED EBV NUCLEAR ANTIGEN-ANTIBODY RESPONSES ARE ASSOCIATED WITH THE DEVELOPMENT OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN SOLID-ORGAN TRANSPLANT RECIPIENTS
    RIDDLER, SA
    BREINIG, MC
    MCKNIGHT, JLC
    BLOOD, 1994, 84 (03) : 972 - 984
  • [49] Detection of EBV DNA in the cord blood donor for a patient developing Epstein–Barr virus-associated lymphoproliferative disorder following mismatched unrelated umbilical cord blood transplantation
    PR Haut
    P Kovarik
    PH Shaw
    D Walterhouse
    HB Jenson
    M Kletzel
    Bone Marrow Transplantation, 2001, 27 : 761 - 765
  • [50] The combination of rituximab (anti-CD20 mAb) and daily low dose interleukin-2 (IL-2) therapy effectively treats established human Epstein-Barr virus-associated lymphoproliferative disorder (EBV-LPD) in a mouse model of human EBV-LPD.
    Carrodeguas, L
    Baiocchi, RA
    Roychowdhury, S
    Peng, RQ
    Orosz, CG
    BLOOD, 1999, 94 (10) : 90A - 90A
12345